Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DOP1 leucine zipper like protein A (DOP1A) is a protein-coding gene belonging to the dopey family, characterized by leucine zipper-like domains. DOP1A is implicated in protein trafficking between the late Golgi and early endosomes, and is predicted to function in Golgi to endosome transport and endoplasmic reticulum organization. Orthologs in fungi (yeast and filamentous species) suggest a critical role in cell morphology and developmental structural organization. Pathogenic variants in DOP1A have been linked to neurodevelopmental disorders, apparently related to abnormal myelinogenesis driven by defects in Golgi-endosome protein traffic. DOP1A localizes to the Golgi membrane, endosome, and trans-Golgi network. No current evidence supports DOP1A as a therapeutic target or as the site of action for any known drug.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DOP1 leucine zipper like protein A (DOP1A).